Sequencing based dissection of inflammation associated natural killer cell remodeling in lung adenocarcinoma identifies state biomarkers and therapeutic vulnerabilities
- 1The First Department of Clinical Medicine, Bengbu Medical University, Bengbu, Anhui, China
- 2Department of Stomatology, Bengbu Medical University, Bengbu, Anhui, China
- 3Department Mental Health, Bengbu Medical University, Bengbu, Anhui, China
Abstract
BackgroundChronic inflammation may shift tissue-protective immunity toward a tumor-permissive microenvironment, but natural killer (NK)-cell remodeling in lung adenocarcinoma (LUAD) remains incompletely characterized. We investigated whether NK-cell depletion and state redistribution are reproducible tumor-associated features with biomarker or therapeutic relevance.MethodsTwo patient-matched single-cell RNA-sequencing cohorts (GSE131907 and E-MTAB-13526) were analyzed using patient-level paired tests. We assessed NK-cell abundance within the immune compartment, CD16-positive terminal and CD16-negative tissue-adapted fractions within NK cells, and pseudobulk expression. Chromatin accessibility was evaluated using GSE304741 GEX–ATAC data. TCGA-LUAD, Visium spatial transcriptomics, and six pretreatment immune checkpoint inhibitor (ICI) cohorts provided external assessment. Western blots in NK-92 cells examined SMAD2 phosphorylation and perforin/granzyme B expression after TGF-β1 stimulation with or without SB431542.ResultsIn GSE131907, NK-cell abundance and terminal-state fractions declined in all 10 matched patients, whereas tissue-adapted fractions increased (all P = 0.00293); these patterns were independently replicated. Pseudobulk effects showed moderate genome-wide concordance (Spearman’s ρ = 0.350), with 112/116 discovery-significant genes directionally concordant and 58 significant in both cohorts (FDR <0.05). In GSE304741, 15/19 prespecified promoters showed differential accessibility, with strong RNA–chromatin concordance (ρ = 0.851). TGF-β, hypoxia, MAPK, EGFR, and estrogen-related signatures changed concordantly across analytical contexts. TCGA-LUAD supported reduced inferred NK abundance and terminal cytotoxic programs. In three LUAD/nonsquamous NSCLC ICI cohorts, clinical benefit was associated with higher terminal cytotoxic activity (Hedges’ g = 0.445, P = 0.0319) and lower abundance-adjusted state balance (g = −0.487, P = 0.0192), but not NK abundance. Visium showed a nonsignificant NK-abundance decrease in four of five patients; NK-state estimates were method-dependent. Qualitative NK-92 immunoblots suggested increased SMAD2 phosphorylation and reduced perforin/granzyme B after TGF-β1, attenuated by SB431542.ConclusionLUAD exhibits reproducible NK-cell depletion accompanied by loss of terminal-state representation and relative enrichment of tissue-adapted states. Terminal cytotoxic programs and abundance-adjusted state balance warrant investigation as biopsy-based biomarkers, whereas KLRC1/NKG2A and TGF-β–hypoxia signaling remain therapeutic hypotheses requiring further validation. These findings do not establish a longitudinal premalignant trajectory.
Related
- Fructose metabolism in pancreatic ductal adenocarcinoma: emerging vulnerabilities in KRAS G12D tumors and therapeutic perspectives with sodium citrate
- Global signatures of Ribonucleotide Excision Repair deficiency and its therapeutic vulnerabilities
- Therapeutic vulnerabilities of the drug-resistant fungal meningitis pathogen Cryptococcus neoformans
- Dissection of mammary cell landscape in ruminal dysbiosis-induced mastitis by single-cell RNA sequencing
- Rewiring the breast cancer immune microenvironment through non-coding RNA-macrophage crosstalk: therapeutic vulnerabilities for immune reprogramming
BibTeX
@article{chang2026sequencing,
title = {{Sequencing based dissection of inflammation associated natural killer cell remodeling in lung adenocarcinoma identifies state biomarkers and therapeutic vulnerabilities}},
author = {Luyuan Chang and Ruiqi Wang and Xin Chen and Yuantao Fang and Jiaqi Yan and Juan Chen and Jing Zhang},
journal = {Frontiers in Genetics},
year = {2026},
month = nov,
doi = {10.3389/fgene.2026.1999349},
url = {https://doi.org/10.3389/fgene.2026.1999349},
note = {CC BY},
}
RIS
TY - JOUR
TI - Sequencing based dissection of inflammation associated natural killer cell remodeling in lung adenocarcinoma identifies state biomarkers and therapeutic vulnerabilities
AU - Luyuan Chang
AU - Ruiqi Wang
AU - Xin Chen
AU - Yuantao Fang
AU - Jiaqi Yan
AU - Juan Chen
AU - Jing Zhang
PY - 2026
DA - 2026/11/04
JO - Frontiers in Genetics
DO - 10.3389/fgene.2026.1999349
UR - https://doi.org/10.3389/fgene.2026.1999349
AB - BackgroundChronic inflammation may shift tissue-protective immunity toward a tumor-permissive microenvironment, but natural killer (NK)-cell remodeling in lung adenocarcinoma (LUAD) remains incompletely characterized. We investigated whether NK-cell depletion and state redistribution are reproducible tumor-associated features with biomarker or therapeutic relevance.MethodsTwo patient-matched single-cell RNA-sequencing cohorts (GSE131907 and E-MTAB-13526) were analyzed using patient-level paired tests. We assessed NK-cell abundance within the immune compartment, CD16-positive terminal and CD16-negative tissue-adapted fractions within NK cells, and pseudobulk expression. Chromatin accessibility was evaluated using GSE304741 GEX–ATAC data. TCGA-LUAD, Visium spatial transcriptomics, and six pretreatment immune checkpoint inhibitor (ICI) cohorts provided external assessment. Western blots in NK-92 cells examined SMAD2 phosphorylation and perforin/granzyme B expression after TGF-β1 stimulation with or without SB431542.ResultsIn GSE131907, NK-cell abundance and terminal-state fractions declined in all 10 matched patients, whereas tissue-adapted fractions increased (all P = 0.00293); these patterns were independently replicated. Pseudobulk effects showed moderate genome-wide concordance (Spearman’s ρ = 0.350), with 112/116 discovery-significant genes directionally concordant and 58 significant in both cohorts (FDR <0.05). In GSE304741, 15/19 prespecified promoters showed differential accessibility, with strong RNA–chromatin concordance (ρ = 0.851). TGF-β, hypoxia, MAPK, EGFR, and estrogen-related signatures changed concordantly across analytical contexts. TCGA-LUAD supported reduced inferred NK abundance and terminal cytotoxic programs. In three LUAD/nonsquamous NSCLC ICI cohorts, clinical benefit was associated with higher terminal cytotoxic activity (Hedges’ g = 0.445, P = 0.0319) and lower abundance-adjusted state balance (g = −0.487, P = 0.0192), but not NK abundance. Visium showed a nonsignificant NK-abundance decrease in four of five patients; NK-state estimates were method-dependent. Qualitative NK-92 immunoblots suggested increased SMAD2 phosphorylation and reduced perforin/granzyme B after TGF-β1, attenuated by SB431542.ConclusionLUAD exhibits reproducible NK-cell depletion accompanied by loss of terminal-state representation and relative enrichment of tissue-adapted states. Terminal cytotoxic programs and abundance-adjusted state balance warrant investigation as biopsy-based biomarkers, whereas KLRC1/NKG2A and TGF-β–hypoxia signaling remain therapeutic hypotheses requiring further validation. These findings do not establish a longitudinal premalignant trajectory.
SN - 1664-8021
ER -